{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:04:40Z","timestamp":1779689080683,"version":"3.53.1"},"reference-count":48,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: Posterior segment eye diseases, including age-related macular degeneration and diabetic retinopathy, are preeminent causes of vision loss worldwide. Effective drug delivery to the retina poses an ongoing therapeutic difficulty due to the presence of the anatomical and physiological barriers. Nanotechnology-based drug delivery systems represent a promising strategy to overcome those limitations. Methods: A narrative literature review was conducted using the PubMed, Scopus, and Google Scholar databases, covering publications published between 2019 and 2026. Publications evaluating nanoparticles for the treatment of the vitreoretinal disorders, including pre-clinical in vitro and in vivo studies, were analyzed. Results: Nanocarriers, including liposomes, polymeric nanoparticles, and lipid-based systems, established improved drug bioavailability, stability, and targeted delivery. The analyzed systems facilitate sustained drug release and potentially reduce the prevalence of invasive intravitreal injections. The nanocarriers\u2019 effectiveness is primarily influenced by their physicochemical properties, such as particle size, surface charge, and encapsulation efficiency. Nonetheless, the production costs and safety aspects, including cytotoxicity, oxidative stress, and inflammatory responses, remain as significant limitations. Conclusions: Nanotechnology-based drug delivery systems serve as an auspicious therapeutic approach for posterior segment eye diseases. However, further standardized preclinical and clinical research is required to assure long-term safety and enable successful clinical transition.<\/jats:p>","DOI":"10.3390\/life16050810","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:33:54Z","timestamp":1779687234000},"page":"810","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6274-0289","authenticated-orcid":false,"given":"Dominika","family":"Skarbek","sequence":"first","affiliation":[{"name":"Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Sochocka","sequence":"additional","affiliation":[{"name":"Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6684-1683","authenticated-orcid":false,"given":"Oliwia","family":"Sid\u0142o","sequence":"additional","affiliation":[{"name":"Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5951-1137","authenticated-orcid":false,"given":"Aleksandra","family":"Sapiaszko","sequence":"additional","affiliation":[{"name":"Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Drab","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Statistics with e-Health Lab, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-8987","authenticated-orcid":false,"given":"Jacek","family":"Baj","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rejdak","sequence":"additional","affiliation":[{"name":"Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1., 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-4371","authenticated-orcid":false,"given":"Joanna","family":"Dolar-Szczasny","sequence":"additional","affiliation":[{"name":"Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1., 20-079 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2019). World Report on Vision, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Antal, R., Beny\u00f3, Z., Nagy, Z.Z., Kov\u00e1cs, I., Fekete, J.T., Gy\u0151rffy, B., and Kov\u00e1cs, K.A. (2025). Recent advances in treating age-related macular degeneration and diabetic retinopathy: Current therapies and emerging novel approaches. GeroScience, Advance online publication.","DOI":"10.1007\/s11357-025-01921-1"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., Garc\u00eda, M.L., Souto, E.B., and S\u00e1nchez-L\u00f3pez, E. (2021). Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010090"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Akhter, M.H., Ahmad, I., Alshahrani, M.Y., Al-Harbi, A.I., Khalilullah, H., Afzal, O., Altamimi, A.S.A., Najib Ullah, S.N.M., Ojha, A., and Karim, S. (2022). Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels, 8.","DOI":"10.3390\/gels8020082"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12951-025-03848-3","article-title":"Advances in nanomedicine-based retinal drug delivery: Mechanisms and translational applications","volume":"24","author":"Nafar","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1350-9462(01)00018-0","article-title":"Transscleral drug delivery to the retina and choroid","volume":"21","author":"Ambati","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/1061186X.2015.1052073","article-title":"Recent developments in ocular drug delivery","volume":"23","author":"Chen","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Conrady, C.D., and Yeh, S. (2021). A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081224"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9394(99)80096-8","article-title":"Human sclera: Thickness and surface area","volume":"125","author":"Olsen","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gugleva, V., and Andonova, V. (2023). Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030474"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hashemi, H., Khabazkhoob, M., Miraftab, M., Emamian, M.H., Shariati, M., Abdolahinia, T., and Fotouhi, A. (2012). The distribution of axial length, anterior chamber depth, lens thickness, and vitreous chamber depth in an adult population of Shahroud, Iran. BMC Ophthalmol., 12.","DOI":"10.1186\/1471-2415-12-50"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/febs.16330","article-title":"The blood-retina barrier in health and disease","volume":"290","author":"Campbell","year":"2023","journal-title":"FEBS J."},{"key":"ref_13","unstructured":"Forrester, J.V., Dick, A.D., McMenamin, P.G., Roberts, F., and Pearlman, E. (2016). The Eye: Basic Sciences in Practice, Elsevier. [4th ed.]."},{"key":"ref_14","unstructured":"Wolff, E., and Warwick, R. (1976). Eugene Wolff\u2019s Anatomy of the Eye and Orbit: Including the Central Connexions, Development, and Comparative Anatomy of the Visual Apparatus, Saunders. [7th ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105115","DOI":"10.1016\/j.phrs.2020.105115","article-title":"Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy","volume":"161","author":"Rudraraju","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bora, K., Kushwah, N., Maurya, M., Pavlovich, M.C., Wang, Z., and Chen, J. (2023). Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods. Cells, 12.","DOI":"10.3390\/cells12202443"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Rudeen","year":"2020","journal-title":"Eye"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shegokar, R. (2020). Preclinical testing\u2014Understanding the basics first. Drug Delivery Aspects, Elsevier.","DOI":"10.1016\/B978-0-12-821222-6.00002-6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2403399","DOI":"10.1002\/advs.202403399","article-title":"Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases","volume":"11","author":"Wu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2100639","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization","volume":"11","author":"Gandek","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Amato, R., Melecchi, A., Pucci, L., Canovai, A., Marracci, S., Cammalleri, M., Dal Monte, M., Caddeo, C., and Casini, G. (2023). Liposome-Mediated Delivery Improves the Efficacy of Lisosan G against Retinopathy in Diabetic Mice. Cells, 12.","DOI":"10.3390\/cells12202448"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18502\/jovr.v19i1.15436","article-title":"Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics","volume":"19","author":"Chaharband","year":"2024","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yessentayeva, N.A., Galiyeva, A.R., Daribay, A.T., Sadyrbekov, D.T., Moustafine, R.I., and Tazhbayev, Y.M. (2024). Optimization of Polylactide-Co-Glycolide-Rifampicin Nanoparticle Synthesis, In Vitro Study of Mucoadhesion and Drug Release. Polymers, 16.","DOI":"10.3390\/polym16172466"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Varela-Fern\u00e1ndez, R., Garc\u00eda-Otero, X., D\u00edaz-Tom\u00e9, V., Regueiro, U., L\u00f3pez-L\u00f3pez, M., Gonz\u00e1lez-Barcia, M., Isabel Lema, M., and Otero-Espinar, F.J. (2022). Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040799"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liu, J., Luo, L., Xu, F., Li, G., Chen, J., Teng, L., Li, Y., and Sun, F. (2020). Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease. Molecules, 25.","DOI":"10.3390\/molecules25214897"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","article-title":"Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration","volume":"16","author":"Qiu","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10837450.2025.2469321","article-title":"Ocular polymeric nanomicelles for the posterior eye segment in the management of retinoblastoma: Formulation, optimization, in vitro and ex vivo evaluations","volume":"30","author":"Ansari","year":"2025","journal-title":"Pharm. Dev. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Razavi, M.S., Ebrahimnejad, P., Fatahi, Y., D\u2019Emanuele, A., and Dinarvand, R. (2022). Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.850757"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yang, C., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., Li, M., and Xu, H. (2022). Nanoparticles in ocular applications and their potential toxicity. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.931759"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.2147\/IJN.S244785","article-title":"Silver Nanoparticle-Induced Apoptosis in ARPE-19 Cells Is Inhibited by Toxoplasma gondii Pre-Infection Through Suppression of NOX4-Dependent ROS Generation","volume":"15","author":"Quan","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"120873","DOI":"10.1016\/j.ijpharm.2021.120873","article-title":"Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery","volume":"606","author":"Silva","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lee, H., and Noh, H. (2023). Advancements in Nanogels for Enhanced Ocular Drug Delivery: Cutting-Edge Strategies to Overcome Eye Barriers. Gels, 9.","DOI":"10.3390\/gels9090718"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"113908","DOI":"10.1016\/j.jconrel.2025.113908","article-title":"Microneedle-mediated biomimetic nanoparticles for targeted antioxidant and anti-inflammatory therapy in age-related macular degeneration","volume":"384","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Liu, L.C., Chen, Y.H., and Lu, D.W. (2023). Overview of Recent Advances in Nano-Based Ocular Drug Delivery. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015352"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: Current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Beirampour, N., Bustos-Salgado, P., Garr\u00f3s, N., Mohammadi-Meyabadi, R., Dom\u00e8nech, \u00d2., Su\u00f1er-Carb\u00f3, J., Rodr\u00edguez-Lagunas, M.J., Kapravelou, G., Montes, M.J., and Calpena, A. (2024). Formulation of Polymeric Nanoparticles Loading Baricitinib as a Topical Approach in Ocular Application. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16081092"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.2147\/IJN.S532074","article-title":"Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases","volume":"20","author":"Lin","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s11671-020-03344-7","article-title":"Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field","volume":"15","author":"Yu","year":"2020","journal-title":"Nanoscale Res. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"124192","DOI":"10.1016\/j.ijpharm.2024.124192","article-title":"Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics","volume":"658","author":"Datta","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s42452-024-06283-5","article-title":"Self-assembled nanoparticles in ocular delivery: A comprehensive review","volume":"7","author":"Tenpattinam","year":"2025","journal-title":"Discov. Appl. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2107315","DOI":"10.1002\/adma.202107315","article-title":"A Hydrogel Ionic Circuit Based High-Intensity Iontophoresis Device for Intraocular Macromolecule and Nanoparticle Delivery","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_43","first-page":"37","article-title":"Nanoparticles in intraocular drug delivery","volume":"37","author":"Klaus","year":"2025","journal-title":"Med. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2204206","DOI":"10.1080\/10717544.2023.2204206","article-title":"Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment","volume":"30","author":"Jiang","year":"2023","journal-title":"Drug Deliv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-020-00745-9","article-title":"Distribution of polymeric nanoparticles in the eye: Implications in ocular disease therapy","volume":"19","author":"Swetledge","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1039\/D3NH00306J","article-title":"Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases","volume":"9","author":"Khalil","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","article-title":"Nanoparticulate Drug Delivery to the Retina","volume":"18","author":"Li","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1039\/D5BM00325C","article-title":"Nanomedicine in ophthalmology: Conquering anatomical barriers and enhancing therapeutic efficacy","volume":"14","author":"Wang","year":"2026","journal-title":"Biomater. Sci."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/810\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:49:55Z","timestamp":1779688195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["life16050810"],"URL":"https:\/\/doi.org\/10.3390\/life16050810","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}